These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15161520)

  • 1. [The correlation of serum DNA level of the chronic hepatitis B and the clinical significance].
    Mei XP; Li J; Zeng Y; Xiong LS; Chang MH; Tan CX
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):313. PubMed ID: 15161520
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between hepatitis B virus markers and quantitative HBV DNA in serum].
    Huang ZX; Chen DY; Zhang QB
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):43. PubMed ID: 14761284
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential clinical diagnostic parameters of acute hepatitis B and flare of chronic HBV infection].
    Zhao H; Tian GS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):363-5. PubMed ID: 15650791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between viral load and genotypes of hepatitis B virus in children with chronic hepatitis B.
    Oommen PT; Wirth S; Wintermeyer P; Gerner P
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):342-7. PubMed ID: 16954957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
    Borgniet O; Parvaz P; Bouix C; Chevallier P; Trépo C; André P; Zoulim F
    J Med Virol; 2009 Aug; 81(8):1336-42. PubMed ID: 19551826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC; Yulugkural Z; Vahaboglu H
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients.
    Lian M; Zhou X; Wei L; Qiu S; Zhou T; Li L; Gu X; Luo M; Zheng X
    Virol J; 2007 Sep; 4():93. PubMed ID: 17892580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
    J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
    Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
    J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual infection in chronic hepatitis C patients.
    Vardareli E; Sariçam T; Ozakyol A; Kircali B; Kasifoglu T
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxcii-ccxciv. PubMed ID: 15244205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lamivudine treatment for hepatitis B].
    Lamivudine Clincal Practice Group
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
    [No Abstract]   [Full Text] [Related]  

  • 15. [Investigation of the relationship between serum nitric oxide levels, HBV-DNA and ALT levels in chronic hepatitis B patients].
    Sener AG; Kirdar S; Serter M; Afşar I; Demir EM; Ceylan C; Aydin N
    Mikrobiyol Bul; 2009 Jan; 43(1):83-9. PubMed ID: 19334384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neopterin levels in patients with chronic hepatitis B.
    Kalkan A; Ozden M; Akbulut H
    Jpn J Infect Dis; 2005 Apr; 58(2):107-9. PubMed ID: 15858291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B.
    Mohamadnejad M; Malekzadeh R
    N Engl J Med; 2004 Jun; 350(26):2719-20. PubMed ID: 15218580
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B.
    Wu IC; Chow NH; Cheng PN; Liu WC; Young KC; Chang WL; Chen CY; Tseng KC; Chang TT
    J Med Virol; 2007 Jun; 79(6):663-9. PubMed ID: 17457902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course.
    Sagnelli E; Coppola N; Marrocco C; Onofrio M; Sagnelli C; Coviello G; Scolastico C; Filippini P
    J Clin Virol; 2006 Mar; 35(3):317-20. PubMed ID: 16316779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey.
    Ozdemir FT; Duman D; Ertem D; Avşar E; Eren F; Ozdoğan O; Kalayci C; Aslan N; Bozdayi AM; Tözün N
    Turk J Gastroenterol; 2005 Dec; 16(4):183-7. PubMed ID: 16547844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.